Restoration of cardiac function by an iron chelator, deferasirox, in a patient with aplastic anemia and cardiac iron overload

被引:3
|
作者
Kiguchi, Toru [1 ]
Ito, Yoshikazu [1 ]
Kimura, Yukihiko [1 ]
Ohyashiki, Kazuma [1 ]
机构
[1] Tokyo Med Univ, Div Hematol, Dept Internal Med 1, Shinjuku Ku, Tokyo 1600023, Japan
关键词
MAGNETIC-RESONANCE;
D O I
10.1007/s12185-009-0310-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:546 / 548
页数:3
相关论文
共 50 条
  • [41] A PATIENT WITH APLASTIC ANEMIA WITH ISOLATED HYPOGONADOTROPIC HYPOGONADISM CAUSED BY TRANSFUSION-ASSOCIATED IRON OVERLOAD
    Sasaki, Sunao
    Nyuuzuki, Hiromi
    Ogawa, Yohei
    Nagasaki, Keisuke
    HORMONE RESEARCH IN PAEDIATRICS, 2017, 88 : 318 - 319
  • [42] Deferasirox (Exjade®) for the Treatment of Iron Overload
    Cappellini, M. D.
    Taher, A.
    ACTA HAEMATOLOGICA, 2009, 122 (2-3) : 165 - 173
  • [43] Efficacy and Safety of Deferasirox Estimated By Serum Ferritin and Labile Plasma Iron Levels in Patients with Aplastic Anemia, Myelodysplastic Syndrome, or Hematologic Malignancy with Transfusional Iron Overload
    Kim, Il Hwan
    Joo, Young Don
    Moon, Joon Ho
    Lim, Sung Nam
    Sohn, Sang Kyun
    Lee, Gyeong Won
    Lee, Ho Sup
    Kwon, Ki Young
    Kim, Sung Hyun
    Park, Kyung Tae
    Chung, Joo Seop
    Lee, Won Sik
    Lee, Sang Min
    Hyun, Myung Soo
    Kim, Hawk
    Ryoo, Hun-Mo
    Bae, Sung Hwa
    BLOOD, 2014, 124 (21)
  • [44] Interdependence of cardiac iron and calcium in a murine model of iron overload
    Otto-Duessel, Maya
    Brewer, Casey
    Wood, John C.
    TRANSLATIONAL RESEARCH, 2011, 157 (02) : 92 - 99
  • [45] Influence of Iron Overload on Immunosuppressive Therapy in Children with Severe Aplastic Anemia
    Pawelec, Katarzyna
    Salamonowicz, Malgorzata
    Panasiuk, Anna
    Leszczynska, Elzbieta
    Krawczuk-Rybak, Maryna
    Demkow, Urszula
    Matysiak, Michal
    NONCOMMUNICABLE DISEASES, 2015, 866 : 83 - 89
  • [46] Deferasirox-Deferoxa ine Combination Therapy Reduces Cardiac Iron With Rapid Liver Iron Removal In Patients With Severe Transfusional Iron Overload (HYPERION)
    Aydinok, Yesim
    Kattamis, Antonis
    Cappellini, M. Domenica
    El-Beshlawy, Amal
    Origa, Raffaella
    Elalfy, Mohsen
    Kilinc, Yurdanur
    Perrotta, Silverio
    Karakas, Zeynep
    Viprakasit, Vip
    Habr, Dany
    Wegener, Antje
    Shen, Junwu
    Porter, John B.
    BLOOD, 2013, 122 (21)
  • [47] The oral iron chelator deferasirox might improve survival in allogeneic hematopoietic cell transplant (alloHSCT) recipients with transfusional iron overload
    Sivgin, Serdar
    Baldane, Suleyman
    Akyol, Gulsah
    Keklik, Muzaffer
    Kaynar, Leylagul
    Kurnaz, Fatih
    Pala, Cigdem
    Zararsiz, Gokmen
    Cetin, Mustafa
    Eser, Bulent
    Unal, Ali
    TRANSFUSION AND APHERESIS SCIENCE, 2013, 49 (02) : 295 - 301
  • [48] Efficacy and safety of deferasirox estimated by serum ferritin and labile plasma iron levels in patients with aplastic anemia, myelodysplastic syndrome, or acute myeloid leukemia with transfusional iron overload
    Kim, Il-Hwan
    Moon, Joon-Ho
    Lim, Sung-Nam
    Sohn, Sang-Kyun
    Kim, Hoon-Gu
    Lee, Gyeong-Won
    Kim, Yang-Soo
    Lee, Ho-Sup
    Kwon, Ki-Young
    Kim, Sung-Hyun
    Park, Kyung-Tae
    Chung, Joo-Seop
    Lee, Won-Sik
    Lee, Sang-Min
    Hyun, Myung-Soo
    Kim, Hawk
    Ryoo, Hun-Mo
    Bae, Sung-Hwa
    Joo, Young-Don
    TRANSFUSION, 2015, 55 (07) : 1613 - 1620
  • [49] Inconsistent hepatic antifibrotic effects with the iron chelator deferasirox
    Sobbe, Amy
    Bridle, Kim R.
    Jaskowski, Lesley
    de Guzman, C. Erika
    Santrampurwala, Nishreen
    Clouston, Andrew D.
    Campbell, Catherine M.
    Subramaniam, V. Nathan
    Crawford, Darrell H. G.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 (03) : 638 - 645
  • [50] The effects of an iron chelator, deferasirox, on the hemorrhagic cellular damage
    Imai, T.
    Nakamura, S.
    Shimazawa, M.
    Hara, H.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2019, 39 : 167 - 167